Copyright Notice
Attribution Statement: LactMed is a registered trademark of the U.S. Department of Health and Human Services.
Bookshelf ID: NBK500690PMID: 29999749
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006-.
CASRN: 171500-79-1
Drug Levels and Effects
Summary of Use during Lactation
Dalbavancin is 93% plasma protein bound and is poorly absorbed orally, so it is not likely to reach the bloodstream of the infant or cause any adverse effects in breastfed infants. If dalbavancin is required by the mother, it is not a reason to discontinue breastfeeding. Monitor the infant for possible effects on the gastrointestinal tract, such as diarrhea, vomiting, and candidiasis (e.g., thrush, diaper rash).
Drug Levels
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
Alternate Drugs to Consider
Clindamycin, Daptomycin, Doxycycline, Linezolid, Trimethoprim-Sulfamethoxazole, Vancomycin
Substance Identification
Substance Name
Dalbavancin
CAS Registry Number
171500-79-1
Drug Class
Breast Feeding
Lactation
Anti-Infective Agents
Anti-Bacterial Agents
Glycopeptides
Lipoglycopeptides
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
- User and Medical Advice Disclaimer
- Drugs and Lactation Database (LactMed) - Record Format
- LactMed - Database Creation and Peer Review Process
- Fact Sheet. Drugs and Lactation Database (LactMed)
- Drugs and Lactation Database (LactMed) - Glossary
- LactMed Selected References
- Drugs and Lactation Database (LactMed) - About Dietary Supplements
- Breastfeeding Links
- PubChem SubstanceRelated PubChem Substances
- Review Vancomycin.[Drugs and Lactation Database (...]Review Vancomycin.. Drugs and Lactation Database (LactMed®). 2006
- Review Telavancin.[Drugs and Lactation Database (...]Review Telavancin.. Drugs and Lactation Database (LactMed®). 2006
- Review Oritavancin.[Drugs and Lactation Database (...]Review Oritavancin.. Drugs and Lactation Database (LactMed®). 2006
- Review Plazomicin.[Drugs and Lactation Database (...]Review Plazomicin.. Drugs and Lactation Database (LactMed®). 2006
- Review Clindamycin.[Drugs and Lactation Database (...]Review Clindamycin.. Drugs and Lactation Database (LactMed®). 2006
- Dalbavancin - Drugs and Lactation Database (LactMed®)Dalbavancin - Drugs and Lactation Database (LactMed®)
- Evaluating Chemical and Other Agent Exposures for Reproductive and Developmental...Evaluating Chemical and Other Agent Exposures for Reproductive and Developmental Toxicity
- Neural Control of Vergence Movements - NeuroscienceNeural Control of Vergence Movements - Neuroscience
- Corynephage omega gene tox encoding diphtheria toxinCorynephage omega gene tox encoding diphtheria toxingi|15475|emb|V01536.1|Nucleotide
- CEL9C7 Chris Martin sorted cDNA library Caenorhabditis elegans cDNA clone cm9c7 ...CEL9C7 Chris Martin sorted cDNA library Caenorhabditis elegans cDNA clone cm9c7 5' similar to Heat shock protein B homologous peptide, mRNA sequencegi|6587|gnl|dbEST|5425|emb|Z14919.1Nucleotide
Your browsing activity is empty.
Activity recording is turned off.
See more...